← Explorer/Network

Reduction in the body content of DDE in the mongolian gerbil treated with sucrose polyester and caloric restriction*1

Mutter LC, Blanke RV, Jandacek RJ +1 more1988Toxicology and Applied PharmacologyJournal Article
10.1016/0041-008x(88)90182-2PubMed
CardiovascularEndocrine (ADH/ACTH/MSH)GastrointestinalHypothalamic-PituitaryImmune/InnateMusculoskeletalNeurologicalOcularRespiratory/Sinus
ActinomycetesBacterial EndotoxinsIndoor Mold (Stachybotrys, Aspergillus, etc.)MycotoxinsVolatile Organic Compounds (VOCs)Water-Damaged Buildings (WDB)

Abstract

It has previously been shown that oral administration to rats of sucrose polyester (SPE4), a nonabsorbable lipophilic binding agent, greatly stimulates the fecal excretion of coorally administered DDT5 (R.J. Jandacek, 1982, Drug Metab. Rev., 13, 695-714). To determine whether this agent would stimulate the excretion of persistent metabolites of DDT stored in body tissues, we treated a group of gerbils with [14C]-DDT and monitored the fecal excretion of radioactivity for several months until a terminal, log-linear phase of excretion was observed. At this point, when greater than 75% of the fecal radioactivity was identified as [14C]DDE, we fed the animals diets containing up to 10% sucrose polyester and found that the rate of excretion of radioactivity in the stool promptly increased two to three times as compared to the rate in the preceding control period. Some rats were subjected to a 25-50% restriction in total food allotment, but this produced no significant change in fecal excretion of total radioactivity. However, when food restriction was combined with administration of sucrose polyester, there was a dramatic, eightfold average increase in excretion of fecal radioactivity. This synergistic effect was reversed (within 24 hr) when the animals were transferred to a normal diet. Measurement of total body radioactivity confirmed that food restriction plus sucrose polyester treatment reduced the body content of the pesticide. We conclude that stimulation of intestinal excretion may offer a new approach to treatment of patients exposed to lipophilic environmental contaminants.

Key Biomarkers

Alpha Melanocyte Stimulating Hormone (MSH)Immunoglobulin E (IgE)LeptinMatrix Metalloproteinase 9 (MMP9)Vascular Endothelial Growth Factor (VEGF)Visual Contrast Sensitivity (VCS)

Symptom Clusters

Cough and shortness of breathFatigueHeadache and light sensitivityMetabolic symptoms (excessive thirst, frequent urination)Muscle and joint painNeurological symptoms (memory loss, concentration difficulty, confusion, word-finding difficulty)Neuropathic symptoms (tingling in extremities)Night sweats and mood/appetite swingsSinus congestion

Cited By (6)

  • Chronic biotoxin-associated illness: Multiple-system symptoms, a vision deficit, and effective treatmentNeurotoxicology and Teratology · 2005
  • Sick building syndrome (SBS) and exposure to water-damaged buildings: Time series study, clinical trial and mechanismsNeurotoxicology and Teratology · 2006
  • A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildingsNeurotoxicology and Teratology · 2005
  • Possible estuary-associated syndrome: symptoms, vision, and treatment.Environmental Health Perspectives · 2001
  • Residential and Recreational Acquisition of Possible Estuary-Associated Syndrome: A New Approach to Successful Diagnosis and TreatmentEnvironmental Health Perspectives · 2001
  • Persistent Organic Pollutants and Neurological Disorders: From Exposure to Preventive InterventionsEmerging contaminants and associated treatment technologies · 2021

References (1)

Related Papers

  • Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarumEnvironmental Health Perspectives · 2004 · 15 shared tags
  • Correction to “Maitotoxin induces biphasic interleukin-1β secretion and membrane blebbing in murine macrophages”Mol Pharmacol · 2004 · 15 shared tags
  • HUMAN VISUAL FUNCTION IN THE NORTH CAROLINA CLINICAL STUDYON POSSIBLE ESTUARY-ASSOCIATED SYNDROMEJournal of Toxicology and Environmental Health · 2001 · 15 shared tags
  • Cholestyramine protection against ochratoxin A toxicity: role of ochratoxin A sorption by the resin and bile acid enterohepatic circulationJournal of Food Protection · 1999 · 15 shared tags
  • In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisinsMycopathologia · 2001 · 15 shared tags
  • Occurrence of Toxigenic Aspergillus versicolor Isolates and Sterigmatocystin in Carpet Dust from Damp Indoor EnvironmentsApplied and Environmental Microbiology · 2002 ·
  • Cholestyramine: Use as a New Therapeutic Approach for Chlordecone (Kepone) PoisoningScience · 1978
  • 15 shared tags